Tag: finance

Post-2008 Wealth Creation: A Guide, Part 3

I intend to make good on my promise of an investing strategy. In part one, I discuss how we’re in a ‘winner take all’, ‘bigger is better’ economic environment dominated by large entities – be it multinational corporations, large content providers, the S&P 500, and the treasury bond market itself. The investment strategy described here… Continue reading Post-2008 Wealth Creation: A Guide, Part 3

Millennials Make a Killing Day Trading on Reddit

Millennials Make a Killing Day Trading on Reddit MarketWatch’s Shawn Langlois and Sally French join Quentin Fottrell and Priya Anand with the details on how Reddit became the go-to place for rowdy millennial traders to gather in 2016. Again, not to make this too political, but many on the left keep repeating the same narratives… Continue reading Millennials Make a Killing Day Trading on Reddit

Defending ‘Theory’ and Rationalism

Some background to understand how the "rationalists" a la Dawkins have a nonscientific view of humans. pic.twitter.com/B4qACpgqgs — NassimNicholasTaleb (@nntaleb) February 4, 2016 Lib Nicholas Nassim Taleb takes another shot at Dawkins. As for the passage itself, there’s room for both theory and empiricism, as I explain in an earlier article Falsifiability, String Theory, and… Continue reading Defending ‘Theory’ and Rationalism

Not Worried About Tech Valuations: Why It May Be Different This Time

In the past month, there have been a plethora of doom and gloom articles about web 2.0, Silicon Valley, the economy, and start-ups. In this series, I address some of the major concerns, arguing that perhaps the doom and gloom is not all warranted. Big-Cap Tech Stocks Are a Sucker Bet We’ve been hearing these… Continue reading Not Worried About Tech Valuations: Why It May Be Different This Time

The Daily View : Stocks Plunge, RIP American Dream, Why Prescription Drugs are so Expensive

Here is the backstory behind the 5,000% price hike of Daraprim. In Martin’s defense, the drug is classified as an ‘orphan drug‘, which means there is little demand due to the rarity of the underlying condition it is supposed to treat. In order for phrama companies to profit from orphan drugs, they have to charge… Continue reading The Daily View : Stocks Plunge, RIP American Dream, Why Prescription Drugs are so Expensive

Collapse Can Wait, Part 2

Aaron is right about America’s reserve currency status, and also there is the petrodollar in addition to the ‘flight to safety’ and other factors that are keeping interest rates low and the dollar high, all thanks to American exceptionalism. As bad as the US economy may seem, other countries are worse, although I am more… Continue reading Collapse Can Wait, Part 2

Better or Worse?

Two contrasting viewpoints: Pessimistic: The Truly New Year Optimistic: Financial Fridays: The Stock Market is Bullshit New inventions and technologies would outpace the demand for those commodities so that as we needed their functionality more, the prices would fall. Think about computers: your price per speed and functionality in your computer has gone down every… Continue reading Better or Worse?

Active Management Continues to Lag Indexes

After a really bad 2014, 2015 proved little better, with the majority of hedge funds, managers, and mutual funds failing to beat the S&P 500. Carl Icahn, Warren Buffett, and Bill Ackman – all of whom are billionaires – lagged the market substantially. Buffett lagged by 13% in 2015 Bill Ackman by 20%. It looks… Continue reading Active Management Continues to Lag Indexes